Tiptuximab

N/A

Report date: 2022/09/09 10:41:04

Base Information

Drug NameTiptuximab
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of Actionanti-TIP-1
TargetsTax-interacting protein 1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedical Guidance Systems LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedical Guidance Systems LLC
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A